Developments in novel breath tests for bacterial and fungal pulmonary infection
Current Opinion in Pulmonary Medicine, 03/29/2012
Chambers ST et al. – Careful attention needs to be paid to the sensitivity and specificity of a technique and confounding from the environment. The role of technologies such as selected ion flow tube–mass spectrometry is emerging. The electronic nose requires further validation for tuberculosis. The identification of specific microbial biomarkers aids the quest for improved accuracy. Exhaled breath condensate is currently of limited value.
